SlideShare una empresa de Scribd logo
1 de 26
Dr. Faran Mahmood
   FCPS Orthop.
   First diagnosed in 1873 by Dr Von Bergmann

   Published in 1879 Fenger and Salisbury.
   Fat Embolism:
    Traumatic fat embolism occurs in up to 90% of
    individuals with severe skeletal injuries, but <
    10% of such patients have any clinical symptoms /
    signs

   Fat Embolism Syndrome:
    FE with clinical manifestation .
   Incidence: 1-3% femur #, 5-10% if bilateral or
    multiple.

   Mortality: 5-15%

   Clinical diagnosis, No specific laboratory test is
    diagnostic

   Mostly associated with long bone/pelvic #s, and
    more frequent in closed fractures.

   Onset is 24-72 hours from initial insult
   A high index of suspicion is needed for diagnosis is
    to be made.

   An asymptomatic latent period - 12-48 hours.

   The fulminant form presents as acute cor pulmonale,
    respiratory failure, - death within a few hours of
    injury.
Mechanical Theory
   Physical obstruction of the pulmonary & systemic
    vasculature with embolized fat.
   Temporary rise in I/M pressure - forces marrow into
    injured venous sinusoids.
   Cor pulmonale - inadequate compensatory pulmonary
    vasodilatation.
   Microvascular lodging - local ischemia and inflammation.
   Release of inflammatory mediators, platelet aggregation,
    & vasoactive amines.
The biochemical theory

   Circulating FFAs -directly toxic to Pneumocytes /
    capillary Endothelium in the lung - interstitial
    hemorrhage, edema & chemical pneumonitis.

   Coexisting shock, hypovolemia and sepsis - reduce liver
    flow exacerbate the toxic effects of FFAs.
H/E stain lung –

- blood vessel with
fibrinoid material and

-optical empty space
-lipid dissolved during
the staining process.
TRAUMA
Hypoxemia




Neurological    Petechial
abnormalities   rash
   Dyspnea,

                 Tachypnea

   Hypoxemia PaO2 < 60 mm Hg
   Clinically Tachpnea, Dyspnea, Hypoxia, rales, pleural
    friction rub & ARDS.
   High spiking temperatures.
   Hypoxemia - ventilation-perfusion mismatch &
    intrapulmonary shunting. Acute cor pulmonale
    -respiratory distress, hypoxemia, hypotension and
    elevated CVP.
   ½ of pts require mechanical ventilation
   CXR normal early on - later may show ‘snowstorm’
    pattern- diffuse bilateral infiltrates
   CT chest: ground glass opacification with interlobular
    septal thickening
   CNS signs usually occur after respiratory symptoms
    - nonspecific - features of diffuse encephalopathy

   Acute confusion, stupor, coma, rigidity, or
    convulsions - Transient and reversible in most cases

   CT Head: general edema – nonspecific

   MRI brain: Low density on T1 & High intensity T2
    signal - correlates to degree of impairment
   Reddish-brown non-palpable Petechial rash - upper
    anterior body, chest, neck, upper arm, axilla,
    shoulder, oral mucous membranes and conjunctivae
    in 20 - 50% patients.

   Pathognomonic, however, it appears late and
    disappears within hours.

   Results from occlusion of dermal capillaries by fat
    globules - extravasations of RBC
   Retinopathy (exudates, cotton wool spots,
    hemorrhage)
   Lipiduria
   Fever
   DIC
   Myocardial depression (R heart strain)
   Thrombocytopenia
   Anemia, Decreased Hematocrit
   Hypocalcemia
Gurd’s criteria

   Most commonly used

   1 major, plus 4 minor
   Continuous pulse oximetry monitoring - at-risk
    patients ( those patients with long bone fractures) -
    detecting desaturations early.

   Consultations recommended include orthopedists,
    neurologists/ neurosurgeons, trauma care specialists,
    critical care specialists, pulmonologists,
    hematologists, and nutritionists.
   The most effective prophylactic measure - operative
    reduction/rigid fixation of long bone fractures as
    soon as possible. Higher incidence (5 fold) when
    fixation delayed greater than 24 hours.

   Supportive care includes maintenance of adequate
    oxygenation and ventilation, stable hemodynamics,
    blood products as clinically indicated, hydration,
    prophylaxis of DVT and stress-related GI bleeding.
   Albumin has been recommended - not only restores
    blood volume / binds fatty acids - may decrease the
    extent of lung injury.

   High dose corticosteroids have been effective in
    preventing development of FES in several trials, but
    controversy on this issue still persists.
   Heparin has also been proposed as it activates
    lipase, but no evidence exists for its use in FES.
   Difficult to predict –FES is frequently subclinical or
    overshadowed by other illnesses or injuries.

   Increased alveolar-to-arterial oxygen gradient and
    neurologic deficits, including coma, may last days
    or weeks.
   As in ARDS, pulmonary sequelae usually resolve
    almost completely within 1 year.

   Residual subclinical diffusion capacity deficits may
    exist.

   Residual neurologic deficits may range from
    nonexistent to subtle personality changes to memory
    and cognitive dysfunction to long-term focal
    deficits.
   Clinical diagnosis so high index of suspicion.

   Most effective management is prevention with rigid
    fixation of fractures within 24 hours

   When developed management is supportive.
Fatembolism

Más contenido relacionado

La actualidad más candente

Cerebral Fat Embolism in ICU
Cerebral Fat Embolism in ICU Cerebral Fat Embolism in ICU
Cerebral Fat Embolism in ICU Dr.Tarek Sabry
 
Fat embolism syndrome
Fat embolism syndromeFat embolism syndrome
Fat embolism syndromeAftab Hussain
 
Pulmonary-Failure-.pptx
Pulmonary-Failure-.pptxPulmonary-Failure-.pptx
Pulmonary-Failure-.pptxWengelRedkiss
 
Fat embolism syndrome
Fat embolism syndromeFat embolism syndrome
Fat embolism syndromeHaziq Mars
 
Non cardiogenic pulmonary oedema
Non cardiogenic pulmonary oedemaNon cardiogenic pulmonary oedema
Non cardiogenic pulmonary oedemaLim Wee Yi
 
DIFFUSE ALVEOLAR HAEMORRHAGE
DIFFUSE ALVEOLAR HAEMORRHAGEDIFFUSE ALVEOLAR HAEMORRHAGE
DIFFUSE ALVEOLAR HAEMORRHAGEAshraf Hefny
 
Cough & hemoptysis & cyanosis & clubbing
Cough & hemoptysis & cyanosis & clubbingCough & hemoptysis & cyanosis & clubbing
Cough & hemoptysis & cyanosis & clubbingPuneet Shukla
 
Child with cyanosis
Child with cyanosisChild with cyanosis
Child with cyanosisSafia Sky
 
Neurogenic Pulmonary Edema
Neurogenic Pulmonary EdemaNeurogenic Pulmonary Edema
Neurogenic Pulmonary EdemaAde Wijaya
 
Neurogenic Pulmonary Edema
Neurogenic Pulmonary Edema Neurogenic Pulmonary Edema
Neurogenic Pulmonary Edema Kamal Bharathi
 
Pulmonary embolism1
Pulmonary embolism1Pulmonary embolism1
Pulmonary embolism1GAMANDEEP
 
Pulmonary embolism ms
Pulmonary embolism msPulmonary embolism ms
Pulmonary embolism mscardilogy
 

La actualidad más candente (19)

Fes
FesFes
Fes
 
Cerebral Fat Embolism in ICU
Cerebral Fat Embolism in ICU Cerebral Fat Embolism in ICU
Cerebral Fat Embolism in ICU
 
Fat embolism syndrome
Fat embolism syndromeFat embolism syndrome
Fat embolism syndrome
 
Pulmonary-Failure-.pptx
Pulmonary-Failure-.pptxPulmonary-Failure-.pptx
Pulmonary-Failure-.pptx
 
Fat embolism syndrome
Fat embolism syndromeFat embolism syndrome
Fat embolism syndrome
 
Fat embolism
Fat embolismFat embolism
Fat embolism
 
Fat embolism
Fat embolismFat embolism
Fat embolism
 
BRAIN-TUMORS.pptx
BRAIN-TUMORS.pptxBRAIN-TUMORS.pptx
BRAIN-TUMORS.pptx
 
Non cardiogenic pulmonary oedema
Non cardiogenic pulmonary oedemaNon cardiogenic pulmonary oedema
Non cardiogenic pulmonary oedema
 
Pulmonary edema
Pulmonary edemaPulmonary edema
Pulmonary edema
 
DIFFUSE ALVEOLAR HAEMORRHAGE
DIFFUSE ALVEOLAR HAEMORRHAGEDIFFUSE ALVEOLAR HAEMORRHAGE
DIFFUSE ALVEOLAR HAEMORRHAGE
 
Cough & hemoptysis & cyanosis & clubbing
Cough & hemoptysis & cyanosis & clubbingCough & hemoptysis & cyanosis & clubbing
Cough & hemoptysis & cyanosis & clubbing
 
Child with cyanosis
Child with cyanosisChild with cyanosis
Child with cyanosis
 
Neurogenic Pulmonary Edema
Neurogenic Pulmonary EdemaNeurogenic Pulmonary Edema
Neurogenic Pulmonary Edema
 
Neurogenic Pulmonary Edema
Neurogenic Pulmonary Edema Neurogenic Pulmonary Edema
Neurogenic Pulmonary Edema
 
Fat embolism
Fat embolismFat embolism
Fat embolism
 
Pulmonary embolism1
Pulmonary embolism1Pulmonary embolism1
Pulmonary embolism1
 
Pulmonary edema
Pulmonary edemaPulmonary edema
Pulmonary edema
 
Pulmonary embolism ms
Pulmonary embolism msPulmonary embolism ms
Pulmonary embolism ms
 

Similar a Fatembolism

fatembolismsyndrome-150804111012-lva1-app6892.pdf
fatembolismsyndrome-150804111012-lva1-app6892.pdffatembolismsyndrome-150804111012-lva1-app6892.pdf
fatembolismsyndrome-150804111012-lva1-app6892.pdfRabeaDia
 
Dr. Radhey Shyam (presentation)
Dr. Radhey Shyam (presentation)Dr. Radhey Shyam (presentation)
Dr. Radhey Shyam (presentation)rsd8106
 
Complications of fractures 3.pptnew
Complications of fractures 3.pptnewComplications of fractures 3.pptnew
Complications of fractures 3.pptnewRakshith Kumar
 
Anesthetic management in Pediatric Neuromuscular disorders
Anesthetic management in Pediatric Neuromuscular disordersAnesthetic management in Pediatric Neuromuscular disorders
Anesthetic management in Pediatric Neuromuscular disordersTikka Mir
 
interstitial lung disease (ilD)
interstitial lung disease (ilD)interstitial lung disease (ilD)
interstitial lung disease (ilD)Mahamad Jamal
 
Respiratory emergencies
Respiratory emergenciesRespiratory emergencies
Respiratory emergenciesFatma Elbadry
 
Pulmonary Arterial Hypertension
Pulmonary Arterial HypertensionPulmonary Arterial Hypertension
Pulmonary Arterial HypertensionAhad Lodhi
 
fat embolism syndrome orthopaedics slides
fat embolism syndrome orthopaedics slidesfat embolism syndrome orthopaedics slides
fat embolism syndrome orthopaedics slidesseethagovin
 
ARDS Anaesthesia seminar 2023.pptx
ARDS Anaesthesia seminar 2023.pptxARDS Anaesthesia seminar 2023.pptx
ARDS Anaesthesia seminar 2023.pptxdrsandeepsinghjadon
 
Pulmonary tromboembolia
Pulmonary tromboemboliaPulmonary tromboembolia
Pulmonary tromboemboliaMedicinaIngles
 
OVERVIEW ON DENGUE HEAMORRAGIC FEVER
OVERVIEW ON DENGUE HEAMORRAGIC FEVEROVERVIEW ON DENGUE HEAMORRAGIC FEVER
OVERVIEW ON DENGUE HEAMORRAGIC FEVERIRJET Journal
 
Endocrinology -pituitary gland
Endocrinology -pituitary glandEndocrinology -pituitary gland
Endocrinology -pituitary glandLih Yin Chong
 

Similar a Fatembolism (20)

Fat embolism
Fat embolismFat embolism
Fat embolism
 
fatembolismsyndrome-150804111012-lva1-app6892.pdf
fatembolismsyndrome-150804111012-lva1-app6892.pdffatembolismsyndrome-150804111012-lva1-app6892.pdf
fatembolismsyndrome-150804111012-lva1-app6892.pdf
 
Fat embolism
Fat embolismFat embolism
Fat embolism
 
Dr. Radhey Shyam (presentation)
Dr. Radhey Shyam (presentation)Dr. Radhey Shyam (presentation)
Dr. Radhey Shyam (presentation)
 
FAT EMBOLISM.pptx
FAT EMBOLISM.pptxFAT EMBOLISM.pptx
FAT EMBOLISM.pptx
 
Complications of fractures 3.pptnew
Complications of fractures 3.pptnewComplications of fractures 3.pptnew
Complications of fractures 3.pptnew
 
Fat Embolism Syndrome
Fat Embolism SyndromeFat Embolism Syndrome
Fat Embolism Syndrome
 
Anesthetic management in Pediatric Neuromuscular disorders
Anesthetic management in Pediatric Neuromuscular disordersAnesthetic management in Pediatric Neuromuscular disorders
Anesthetic management in Pediatric Neuromuscular disorders
 
interstitial lung disease (ilD)
interstitial lung disease (ilD)interstitial lung disease (ilD)
interstitial lung disease (ilD)
 
Respiratory emergencies
Respiratory emergenciesRespiratory emergencies
Respiratory emergencies
 
Pulmonary Arterial Hypertension
Pulmonary Arterial HypertensionPulmonary Arterial Hypertension
Pulmonary Arterial Hypertension
 
fat embolism syndrome orthopaedics slides
fat embolism syndrome orthopaedics slidesfat embolism syndrome orthopaedics slides
fat embolism syndrome orthopaedics slides
 
ARDS, PE, Fat embolism.ppt
ARDS, PE, Fat embolism.pptARDS, PE, Fat embolism.ppt
ARDS, PE, Fat embolism.ppt
 
ARDS Anaesthesia seminar 2023.pptx
ARDS Anaesthesia seminar 2023.pptxARDS Anaesthesia seminar 2023.pptx
ARDS Anaesthesia seminar 2023.pptx
 
vasculitis
vasculitis vasculitis
vasculitis
 
Pulmonary Sarcoidosis
Pulmonary SarcoidosisPulmonary Sarcoidosis
Pulmonary Sarcoidosis
 
Ards
ArdsArds
Ards
 
Pulmonary tromboembolia
Pulmonary tromboemboliaPulmonary tromboembolia
Pulmonary tromboembolia
 
OVERVIEW ON DENGUE HEAMORRAGIC FEVER
OVERVIEW ON DENGUE HEAMORRAGIC FEVEROVERVIEW ON DENGUE HEAMORRAGIC FEVER
OVERVIEW ON DENGUE HEAMORRAGIC FEVER
 
Endocrinology -pituitary gland
Endocrinology -pituitary glandEndocrinology -pituitary gland
Endocrinology -pituitary gland
 

Fatembolism

  • 1. Dr. Faran Mahmood FCPS Orthop.
  • 2. First diagnosed in 1873 by Dr Von Bergmann  Published in 1879 Fenger and Salisbury.
  • 3. Fat Embolism: Traumatic fat embolism occurs in up to 90% of individuals with severe skeletal injuries, but < 10% of such patients have any clinical symptoms / signs  Fat Embolism Syndrome: FE with clinical manifestation .
  • 4. Incidence: 1-3% femur #, 5-10% if bilateral or multiple.  Mortality: 5-15%  Clinical diagnosis, No specific laboratory test is diagnostic  Mostly associated with long bone/pelvic #s, and more frequent in closed fractures.  Onset is 24-72 hours from initial insult
  • 5.
  • 6. A high index of suspicion is needed for diagnosis is to be made.  An asymptomatic latent period - 12-48 hours.  The fulminant form presents as acute cor pulmonale, respiratory failure, - death within a few hours of injury.
  • 7. Mechanical Theory  Physical obstruction of the pulmonary & systemic vasculature with embolized fat.  Temporary rise in I/M pressure - forces marrow into injured venous sinusoids.  Cor pulmonale - inadequate compensatory pulmonary vasodilatation.  Microvascular lodging - local ischemia and inflammation.  Release of inflammatory mediators, platelet aggregation, & vasoactive amines.
  • 8. The biochemical theory  Circulating FFAs -directly toxic to Pneumocytes / capillary Endothelium in the lung - interstitial hemorrhage, edema & chemical pneumonitis.  Coexisting shock, hypovolemia and sepsis - reduce liver flow exacerbate the toxic effects of FFAs.
  • 9. H/E stain lung – - blood vessel with fibrinoid material and -optical empty space -lipid dissolved during the staining process.
  • 11. Hypoxemia Neurological Petechial abnormalities rash
  • 12. Dyspnea,  Tachypnea  Hypoxemia PaO2 < 60 mm Hg
  • 13. Clinically Tachpnea, Dyspnea, Hypoxia, rales, pleural friction rub & ARDS.  High spiking temperatures.  Hypoxemia - ventilation-perfusion mismatch & intrapulmonary shunting. Acute cor pulmonale -respiratory distress, hypoxemia, hypotension and elevated CVP.  ½ of pts require mechanical ventilation  CXR normal early on - later may show ‘snowstorm’ pattern- diffuse bilateral infiltrates  CT chest: ground glass opacification with interlobular septal thickening
  • 14. CNS signs usually occur after respiratory symptoms - nonspecific - features of diffuse encephalopathy  Acute confusion, stupor, coma, rigidity, or convulsions - Transient and reversible in most cases  CT Head: general edema – nonspecific  MRI brain: Low density on T1 & High intensity T2 signal - correlates to degree of impairment
  • 15. Reddish-brown non-palpable Petechial rash - upper anterior body, chest, neck, upper arm, axilla, shoulder, oral mucous membranes and conjunctivae in 20 - 50% patients.  Pathognomonic, however, it appears late and disappears within hours.  Results from occlusion of dermal capillaries by fat globules - extravasations of RBC
  • 16. Retinopathy (exudates, cotton wool spots, hemorrhage)  Lipiduria  Fever  DIC  Myocardial depression (R heart strain)  Thrombocytopenia  Anemia, Decreased Hematocrit  Hypocalcemia
  • 17. Gurd’s criteria  Most commonly used  1 major, plus 4 minor
  • 18.
  • 19. Continuous pulse oximetry monitoring - at-risk patients ( those patients with long bone fractures) - detecting desaturations early.  Consultations recommended include orthopedists, neurologists/ neurosurgeons, trauma care specialists, critical care specialists, pulmonologists, hematologists, and nutritionists.
  • 20. The most effective prophylactic measure - operative reduction/rigid fixation of long bone fractures as soon as possible. Higher incidence (5 fold) when fixation delayed greater than 24 hours.  Supportive care includes maintenance of adequate oxygenation and ventilation, stable hemodynamics, blood products as clinically indicated, hydration, prophylaxis of DVT and stress-related GI bleeding.
  • 21. Albumin has been recommended - not only restores blood volume / binds fatty acids - may decrease the extent of lung injury.  High dose corticosteroids have been effective in preventing development of FES in several trials, but controversy on this issue still persists.
  • 22. Heparin has also been proposed as it activates lipase, but no evidence exists for its use in FES.
  • 23. Difficult to predict –FES is frequently subclinical or overshadowed by other illnesses or injuries.  Increased alveolar-to-arterial oxygen gradient and neurologic deficits, including coma, may last days or weeks.
  • 24. As in ARDS, pulmonary sequelae usually resolve almost completely within 1 year.  Residual subclinical diffusion capacity deficits may exist.  Residual neurologic deficits may range from nonexistent to subtle personality changes to memory and cognitive dysfunction to long-term focal deficits.
  • 25. Clinical diagnosis so high index of suspicion.  Most effective management is prevention with rigid fixation of fractures within 24 hours  When developed management is supportive.